04699nam 2200733Ia 450 991081546340332120200520144314.00-470-92277-X1-282-88900-197866128890040-470-91091-70-470-91090-9(CKB)2670000000056431(EBL)698802(OCoLC)694941437(SSID)ssj0000413548(PQKBManifestationID)11319705(PQKBTitleCode)TC0000413548(PQKBWorkID)10383757(PQKB)10681637(MiAaPQ)EBC698802(Au-PeEL)EBL698802(CaPaEBR)ebr10510325(CaONFJC)MIL288900(OCoLC)632070275(FINmELB)ELB179649(EXLCZ)99267000000005643120100519d2011 uy 0engur|n|---|||||txtccrCardiovascular effects of inhaled ultrafine and nanosized particles /edited by Flemming R. Cassee, Nicholas L. Mills, David Newby1st ed.Hoboken, N.J. John Wileyc20111 online resource (608 p.)Description based upon print version of record.0-470-43353-1 Includes bibliographical references and index.CARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLESCHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESISCHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSISPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plateThis book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.HeartToxicologyAirPollutionToxicologyNanoparticlesToxicologyPulmonary toxicologyHeartToxicology.AirPollutionToxicology.NanoparticlesToxicology.Pulmonary toxicology.616.1/2071Cassee Flemming R1717859Mills Nicholas L1717860Newby David E1717861MiAaPQMiAaPQMiAaPQBOOK9910815463403321Cardiovascular effects of inhaled ultrafine and nanosized particles4114451UNINA